SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-125153
Filing Date
2020-11-13
Accepted
2020-11-13 17:15:50
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029532d1_10q.htm 10-Q 725767
2 EXHIBIT 10.1 tm2029532d1_ex10-1.htm EX-10.1 32370
3 EXHIBIT 31.1 tm2029532d1_ex31-1.htm EX-31.1 7092
4 EXHIBIT 31.2 tm2029532d1_ex31-2.htm EX-31.2 7092
5 EXHIBIT 32.1 tm2029532d1_ex32-1.htm EX-32.1 3739
6 EXHIBIT 32.2 tm2029532d1_ex32-2.htm EX-32.2 3718
  Complete submission text file 0001104659-20-125153.txt   4620478

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT capr-20200930.xml EX-101.INS 910395
8 XBRL TAXONOMY EXTENSION SCHEMA capr-20200930.xsd EX-101.SCH 47639
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20200930_cal.xml EX-101.CAL 32664
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20200930_def.xml EX-101.DEF 167803
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20200930_lab.xml EX-101.LAB 356167
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20200930_pre.xml EX-101.PRE 300636
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 201312557
SIC: 2834 Pharmaceutical Preparations